MarketTwits
267K subscribers
79K photos
2.99K videos
1.1K files
83.6K links
Вся информация на канале не является рекомендацией

связь - @MarketTwits_info
связь - info.markettwits@yandex.ru
VK - https://vk.com/id635239814

№ 4943378258
Download Telegram
🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:

ВВЕРХ


#BPMX +73% Biopharmx Corp -after the company announced that its Phase 2b trial of BPX-04 for Populopustular Rosacea met both primary and secondary endpoints and was well tolerated.

#AGN +29% Allergan plc - after AbbVie Inc
#ABBV announced plans To acquire Allergan for $188.24 per share in cash and stock.

#RIOT +16% Riot Blockchain, Inc. - after climbing 10% on Monday.

#IGC +11% India Globalization Capital, Inc. -after surging 25% on Monday.

#JAGX +10% Jaguar Health, Inc.-regained compliance with all applicable Nasdaq Stock Market listing standards.

#SCPH +5% scPharmaceuticals Inc.

#ENDP +5% Endo International plc -after dropping 6% on Monday.

#KRYS +5% Krystal Biotech Inc -priced 2.5 million share public offering of common stock at $40 per share.

#LEN +4% Lennar Corporation -after the company announced better-than-expected results for its second quarter.

#ARQL +4% ArQule, Inc. -priced 9.25 million share offering at $9.75 per share.

#FDS +4% FactSet Research Systems Inc. -after reporting upbeat Q3 results.

#CANF +4% Can-Fite BioPharma Ltd. -after declining 6% on Monday.

#BHC +4% Bausch Health Companies Inc -after the company announced the US launch of DUOBRII lotion 0.01%/0.045% for plaque psoriasis in adults.

#GNFT +3% Genfit SA- after announcing a strategic partnership with Terns Pharmaceuticals to develop and commercialize elafibranor in Greater China. The company will receive an upfront payment of $35 million.

#SBGL +3% Sibanye Gold Limited

#GRUB +3% Grubhub Inc. -Citigroup upgraded GrubHub from Neutral to Buy.

#NBRV +2% Nabriva Therapeutics PLC – ADR -after reporting the EMA validated the marketing authorization application for lufamulin.

ВНИЗ

#CNAT -58% Conatus Pharmaceuticals Inc - after reporting that top-line results from the ENCORE-LF trial of emricasan did not meet the primary endpoint and will discontinue further treatment of patients enrolled.

#ALDX -23% Aldeyra Therapeutics Inc -after the company announced its SOLACE trial in noninfectious anterior uveitis did not achieve statistical significance in its primary or secondary endpoints.

#KERN -11%Akerna Corp. -after dropping 14.09% on Monday.

#IMUX -11% Immunic, Inc. -after rising 90% on Monday.

#GMDA -10% Gamida Cell Ltd -after the company filed for a common stock offering of 4.04 million shares.

#ABBV -9% AbbVie Inc. -after the company announced it will acquire Allergan for $188.24/share.

#BHF -7% Brighthouse Financial, Inc. -Credit Suisse downgraded Brighthouse Financial from Neutral to Underperform and lowered the price target from $35 to $22, while Goldman Sachs downgraded the stock from Neutral to Sell and lowered the price target from $39 to $32.

#MDCO -5% The Medicines Company -after reporting a $150 million common stock offering.

#PVTL -4% Pivotal Software, Inc.

#AMAG -4% AMAG Pharmaceuticals, Inc. -after dropping 4% on Monday.

#BYND -3% Beyond Meat, Inc. - after dropping 8% on Monday.

#SHOP -3% Shopify Inc. -Wedbush downgraded Shopify from Outperform to Neutral.

#NERV -3% Minerva Neurosciences, Inc. -after surging 40% on Monday.
🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:

ВВЕРХ

#ACAD +85% ACADIA Pharmaceuticals Inc. -after the company disclosed that its Phase 3 HARMONY trial met its primary endpoint.

#CYOU +53% Changyou.com Limited - after receiving an acquisition offer from Sohu.com Limited #SOHU at $10 per ADS.

#KOOL +19% Cesca Therapeutics Inc. - after entering into a supply agreement with Corning.

#MNK +11% Mallinckrodt plc - after surging 17% on Friday.

#ZSAN +8% Zosano Pharma Corporation

#LJPC +7% La Jolla Pharmaceutical Company

#OSTK +7% Overstock.com, Inc. - after gaining 4% on Friday.

#NTNX +7% Nutanix, Inc. -Susquehanna upgraded Nutanix from Negative to Positive and raised the price target from $23 to $45.

#ACHV +7% Achieve Life Sciences, Inc.

#APTS +6% Preferred Apartment Communities, Inc.

#NERV +6% Minerva Neurosciences, Inc.

#EXR +5% Extra Space Storage Inc.

#BXP +5% Boston Properties, Inc. -after the company announced the acquisition of 2 buildings for $106 million in cash.

#PSTG +5% Pure Storage, Inc. - Susquehanna upgraded Pure Storage from Neutral to Positive and raised the price target from $16 to $25.

#VFF +5% Village Farms International, Inc. -after the company reported Pure Sunfarms' receipt of license amendment to supply cannabis products directly to provincial/territorial wholesalers and authorized private retailers.

#SOHU +4% Sohu.com Limited - after the company announced delivery of preliminary non-binding proposal to acquire Changyou.com for $10 per ADS.

#RH +4% RH

#LLY +3.5% Eli Lilly and Company - after reporting positive results for selpercatinib (LOXO-292).

#SLP +3% Simulations Plus, Inc.

#BURL +3% Burlington Stores, Inc.

ВНИЗ

#LUNA -11% Luna Innovations Incorporated

#MRTX -7% Mirati Therapeutics, Inc.- Jefferies upgraded Mirati Therapeutics from Hold to Buy and raised the price target from $89 to $105.

#TOPS -5% Top Ships Inc.

#DRD -5% DRDGOLD Limited - after dropping 5.13% on Friday.

#ENDP -5% Endo International plc - after surging 47% on Friday.

#AMGN -5% Amgen Inc. - after reporting new data from its Phase 1 study evaluating AMG 510 in patients with previously treated KRAS G12C-mutated solid tumors..

#PERI -4% Perion Network Ltd.

#CVET -3% Covetrus, Inc. -Goldman Sachs initiated coverage on Covetrus with a Sell rating and a $11 price target.

#CSIQ -2% Canadian Solar Inc.

#SAVE -2% Spirit Airlines, Inc. - Buckingham downgraded Spirit Airlines from Buy to Neutral and lowerd the price target from $69 to $41.
🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:

ВВЕРХ

#PRTK +42% Paratek Pharmaceuticals, Inc. - the Department of Human Health, Office of the Assistant Secretary for Preparedness and Response, and Biomedical Advanced Research and Development Authority, has awarded it a five-year contract, with an option to extend it to 10 years, to support the development of its Nuzyra for the treatment of pulmonary anthrax.

#RAD +22% Rite Aid Corporation - reported better-than-expected Q3 EPS and sales results. The company also issued FY20 EPS guidance above analyst estimates.

#INO +12% Inovio Pharmaceuticals, Inc. -Roth Capital initiated coverage on Inovio Pharmaceuticals with a Buy rating and a $13 price target.

#MOSC +10% Mosaic Acquisition Corp. - Vivint Smart Home and Mosaic Acquisition announced revised transaction terms.

#SNDL +8% Sundial Growers Inc. - after falling 10% on Wednesday. Sundial Growers reported an initiative to enter Canadian medical cannabis business.

#CAG +8% Conagra Brands, Inc. -after the company reported upbeat earnings for its second quarter.

#PING +7% Ping Identity Holding Corp.

#AXSM +7% Axsome Therapeutics, Inc. - priced its 2 million share offering at $87 per share.

#SGEN +6% Seattle Genetics, Inc. - Seattle Genetics and Astellas Pharma said the FDA has granted accelerated approval for Padcev for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a PD-1/L1 inhibitor and a platinum-containing chemotherapy before or after surgery or in a locally advanced or metastatic setting.

#I +5% Intelsat S.A. - after gaining 8% on Wednesday.

#OBSV +5% ObsEva SA

#RUBI +5% the Rubicon Project, Inc. -Rubicon Project and Telaria reported an all stock merger.

#MTCH +4% Match Group, Inc. - announced an agreement with IAC to separate itself from the remaining businesses of IAC.

#MU +4% Micron Technology, Inc.- reported better-than-expected Q1 sales results.

#QIWI +3% Qiwi plc - after dropping 11% on Wednesday.

#AGS +3% PlayAGS, Inc.

#REVG +3% Rev Group Inc - reported better-than-expected Q4 sales results. The company also issued FY20 sales guidance above analyst estimates.

ВНИЗ

#NERV -24% Minerva Neurosciences, Inc. -said the Phase 2b study that evaluated MIN-117 in adult patients with moderate to severe major depressive disorder, or MDD, failed to meet its primary and key secondary endpoints. The company said it has no plans for further clinical development of the molecule in MDD.

#APOG -15% Apogee Enterprises, Inc. - reported worse-than-expected Q3 EPS and sales results. The company also cut FY20 EPS guidance below analyst estimates.

#KODK -14% Eastman Kodak Company -after surging 12% on Wednesday.

#MLHR Herman Miller, Inc. - after the company reported worse-than-expected Q2 sales results. The company also issued Q3 EPS guidance below analyst estimates.

#ASLN -7% ASLAN Pharmaceuticals Limited - after gaining 10% on Wednesday.

#AKRX -6% Akorn, Inc. - after declining 27% on Wednesday.

#XCUR -5% Exicure, Inc. - reported a common stock offering with no size disclosed.

#NIHD -5% NII Holdings, Inc.

#BNTX -5% BioNTech SE -after dropping 5% on Wednesday.

#DRI -4% Darden Restaurants, Inc. - reported second-quarter earnings results.

#YCBD -3% cbdMD, Inc. - reported Q4 results.